Andere Sprachen Hubei Jumpcan Pharmaceutical Co., Ltd.

Aktien

A0M4HF

CNE0000018X6

600566

Schlusskurs Shanghai S.E. Andere Börsenplätze 00:00:00 22.05.2024			% 5 Tage	% 1. Jan.
37,92 ^CNY	-1,46 %		-6,39 %	+20,65 %

19.04.	Hubei Jumpcan Pharmaceutical Co., Ltd. meldet Ergebnis für das erste Quartal bis zum 31. März 2024	CI
09.04.	Hubei Jumpcan Pharmaceutical Co., Ltd. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Hubei Jumpcan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	19.04.
Hubei Jumpcan Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	09.04.
Tranche Update on Hubei Jumpcan Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 4, 2023.	03.04.
Tranche Update on Hubei Jumpcan Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 4, 2023.	03.01.
Jumpcan Pharma Registers Two New Drugs	02.11.
Hubei Jumpcan Pharma’s Q3 Profit Jumps 4.8%, Revenue Falls 6%	23.10.23
Hubei Jumpcan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	22.10.23
Nanjing Zenshine Pharmaceuticals Co., Ltd. announced that it has received CNY 100 million in funding from Hubei Jumpcan Pharmaceutical Co., Ltd., Kunlun Capital, Zhejiang Saizhi Bole Equity Investment Management Co., Ltd, Zhongshan Zhonghui Investment Group Co.,ltd.	13.10.23
Tranche Update on Hubei Jumpcan Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 4, 2023.	10.10.23
Nanjing Zenshine Pharmaceuticals Co., Ltd. announced that it expects to receive CNY 60 million in funding from Hubei Jumpcan Pharmaceutical Co., Ltd.	18.09.23
Hubei Jumpcan Pharma Registers Oral Solution to Treat ADHD	12.09.23
Hubei Jumpcan Pharma Logs Double-Digit Earnings Growth in H1 on Strong Sales, Reduced Costs; Shares Jump 5%	14.08.23
Hubei Jumpcan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	13.08.23
Hubei Jumpcan Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 40 million worth of its shares.	04.07.23
Hubei Jumpcan Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	03.07.23
Hubei Jumpcan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	17.04.23
Hubei Jumpcan Pharma to Apply For Up to 2 Billion Yuan Loan in 2023	10.04.23
China's Weibo ups stake in Inmyshow Digital with $315 million acquisition	01.03.23
Hubei Jumpcan Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	19.01.23
Rating Agency Ends Rating Hubei Jumpcan Pharmaceutical's Bonds	18.11.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Hubei Jumpcan Pharmaceutical Co., Ltd.

Aktien

A0M4HF

CNE0000018X6

600566

Andere Sprachen

Filter